<unk>  may interact with the following drugs: * Calcium channel blockers of the diltiazem/verapamil type: Intravenous treatment with<unk>  and concomitant calcium channel blocker treatment may lead to severe cardiovascular collapse, abnormal heart rhythms, myocardial depressions, and high blood potassium. * Nondepolarizing neuromuscular blocking agents, such as vecuronium bromide: Neuromuscular blockade is potentiated. * CNS depressants: Sedative action is potentiated. Benzodiazepines may also cause additive muscle weakness. * Combined oral contraceptives and hormone replacement therapy with estrogens may enhance liver toxicity of<unk> , particularly in women over 35 years of age.
Dantrolene
Atogepant
Seltorexant
Clorotepine
Dezocine
Cidoxepin
Bocasan
Lemborexant